Geode Capital Management, LLC Annovis Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 99,114 shares of ANVS stock, worth $590,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,114
Previous 76,233
30.01%
Holding current value
$590,719
Previous $439,000
81.78%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ANVS
# of Institutions
46Shares Held
1.17MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$2.27 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$612,0440.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$600,2250.0% of portfolio
-
Group One Trading, L.P. Chicago, IL52.8KShares$314,4910.02% of portfolio
-
Quest Partners LLC New York, NY46KShares$274,1710.03% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $48.7M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...